Gelonghui March 20 丨 Some investors asked Haite Biotech (300683.SZ) on the investor interactive platform, “Please ask when the CPT overseas project will begin.” The company replied that the company will consider carrying out CPT overseas clinical trials in due course and seek listing.
海特生物(300683.SZ)：会考虑适时开展CPT在海外的临床并谋求上市
Haite Biotech (300683.SZ): Will consider carrying out CPT clinical trials overseas in due course and seek listing
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.